SCHEMBL4596878

SCHEMBL4596878

Cc1cc(Cl)ccc1-c1cccc2c1O[CH]C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.37
CRHR1 P34998 2/20 0.33
GRM2 Q14416 1/20 0.33
HRH4 Q9H3N8 3/20 0.32
CASP3 P42574 2/20 0.31
TAAR1 Q96RJ0 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RAB9A P51151 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HTR1A P08908 1/20 0.31
HTR7 P34969 1/20 0.31
CYP1A2 P05177 1/20 0.31
SCN5A Q14524 1/20 0.31
SCN9A Q15858 1/20 0.31
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5595955 0.88 NPC1 (0.34) CRHR1HRH4CASP3KDM4ENPC1
SCHEMBL27723639 0.79 ALDH1A1 (0.42) HRH4KDM4ENPC1ALDH1A1RAB9A
SCHEMBL27703091 0.79 DPP4 (0.34)
SCHEMBL5583557 0.77 HTR1A (0.44) NOTUMTAAR1NPC1RAB9AHTR1A
SCHEMBL5583422 0.76 CNR2 (0.33) HTR1A
SCHEMBL27703095 0.76 DPP4 (0.34)
SCHEMBL4596881 0.75 NOTUM (0.36) NOTUMCRHR1GRM2HRH4CASP3
SCHEMBL4595395 0.74 PARP1 (0.43) NOTUMHTR1A
SCHEMBL4595393 0.73 AQP1 (0.36) NOTUMCRHR1GRM2TAAR1NPC1
SCHEMBL4962170 0.73 HTR2A (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007509174-A 2007-04-12 JP claimed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP claimed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO claimed
EP-1998764-A2 METHODS FOR TREATING COGNITIVE AND OTHER DISORDERS Wyeth a Corporation of the State of Delaware (US) 2008-12-10 EP disclosed
EP-1874750-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth Incoporated (US) 2008-01-09 EP disclosed
WO-2007112065-A2 METHODS FOR TREATING COGNITIVE AND OTHER DISORDERS WYETH (US) 2007-10-04 WO disclosed